NOS2 and hepatocellular carcinoma: Data indicate that NF-κB activation by IL-1β/TNFα, likely mediated by an active proximal NF-κB site at −85 to −76 bp relative to the TSS (8), supports STAT1 binding to the iNOS promoter in murine Hepa1-6 hepatoma cells.